Benefit Plans (Tables)

9 Months Ended

Jul. 31, 2023

Benefit Plans

Schedule of Share-Based Compensation Reflected in Consolidated Statement of Operations and Comprehensive Loss

Share-based compensation was reflected in the Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):

	Three Months Ended July 31,				Nine Months Ended July 31,
	2023		2022		2023		2022
Cost of revenues	$	389	$	175	$	1,137	$	512
Administrative and selling expense		2,285		1,598		6,546		4,126
Research and development expense		375		135		1,034		319
	$	3,049	$	1,908	$	8,717	$	4,957

Summary of RSA and RSU Activity

The following table summarizes our RSU activity for the nine months ended July 31, 2023:

Restricted Stock Units	Shares	Weighted-Average Fair Value
Outstanding as of October 31, 2022	2,520,881	$	7.93
Granted - PSUs	1,124,953		5.50
Granted - time-vesting RSUs	3,781,370		3.41
Vested	(261,059)		7.03
Forfeited	(64,056)		7.55
Outstanding as of January 31, 2023	7,102,089	$	5.18
Granted - time-vesting RSUs	64,550		3.29
Vested	(84,669)		5.96
Forfeited	(42,000)		3.65
Outstanding as of April 30, 2023	7,039,970	$	5.16
Granted - time-vesting RSUs	400,197		2.36
Vested	(22,732)		4.11
Forfeited	(136,483)		4.75
Outstanding as of July 31, 2023	7,280,952	$	5.03